Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The White House and the US Food and Drug Administration have given their approval to send and allow the use of an experimental Ebola drug, Zmapp, in Liberia.
Subscribe to our email newsletter
The approval follows after a request from the Liberian Government on 8 August to send sample doses of experimental Serum for use on two Liberian doctors who are currently infected with the deadly Ebola virus disease.
According to an Executive Mansion release, the experimental drugs will be delivered to Liberia by a representative of the US Government later this week.
The World Health Organization (WHO) executive director Dr Margaret Chan has authorised the dispatch of additional doses of the experimental Serum to Liberia to support the treatment of affected doctors.
The experimental Serum from the WHO will be brought in by one of its experts later this week.
Zmapp is currently under development with California-based drugmaker Mapp Biopharmaceutical and has been tested only on monkeys. However, the drug is yet to be assessed for safety in humans.
The US has used the serum on two aid workers and on a priest. The workers have showed signs of improvement, while the priest is currently being treated in a hospital in Madrid, reported BBC.
Ebola has been reported to have claimed the lives of more than 1,000 people in the Liberia, Sierra Leone and Guinea, Africa.